RECOVERY - Validation of Universal Influenza Vaccine Assay
Award Notice Posted
- Solicitation number
- NIHAO2010047
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Awarded
- to Leidos Aspenmed Services LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSN272201000172U Federal contract award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Not on record
- Place of performance
- Gaithersburg, Maryland, United States
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
The deliverable of this order is completion of testing and validation of a universal influenza vaccine assay using unique analytical assays and tools (e.g., automation of cloning process for human monoclonal antibody production; micro-viral neutralization assay and automation) developed by the NIAID. The Contractor will test and validate these unique analytical assays and tools, test correlates between the micro-neutralization assay and the historically used hemagglutination assays, and deliver a validated assay to the NIAID suitable for vaccine licensure. Contractor DUNS: 87-893-3951
Update #1 ·
**THIS NOTICE IS PROVIDED FOR INFORMATION PURPOSES ONLY. THIS OPPORTUNITY IS AVAILABLE ONLY TO SELECTED CONTRACTORS UNDER GSA SCHEDULE 621I** The National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for technical immunological support. The deliverable of this order is completion of testing and validation of a universal influenza vaccine assay using unique analytical assays and tools (e.g., automation of cloning process for human monoclonal antibody production; micro-viral neutralization assay and automation) developed by the NIAID. The Contractor will test and validate these unique analytical assays and tools, test correlates between the micro-neutralization assay and the historically used hemagglutination assays, and deliver a validated assay to the NIAID suitable for vaccine licensure. Anticipated period of performance is April 1, 2010 through August 31, 2013.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity